tiprankstipranks
Trending News
More News >
Algernon Pharmaceuticals (TSE:AGN)
:AGN
Canadian Market
Advertisement

Algernon Pharmaceuticals (AGN) Financial Statements

Compare
38 Followers

Algernon Pharmaceuticals Financial Overview

Algernon Pharmaceuticals's market cap is currently $2.40M. The company's EPS TTM is C$-0.02; its P/E ratio is 2.79; Algernon Pharmaceuticals is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in CAD

Algernon Pharmaceuticals Earnings and Revenue History

Algernon Pharmaceuticals Debt to Assets

Algernon Pharmaceuticals Cash Flow

Algernon Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis